Highlights from the updated joint ASNC/SNMMI PET myocardial perfusion and metabolism clinical imaging guidelines

Journal of Nuclear Medicine

Volumn 57, Issue 9, 2016, Pages 1327-1328

  Dilsizian, Vasken ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

CARDIAC IMPLANT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL FEATURE; CLINICAL PRACTICE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEVICE INFECTION; DIAGNOSTIC ACCURACY; EDITORIAL; HEALTH CARE QUALITY; HEART MUSCLE BLOOD FLOW; HEART VALVE PROSTHESIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR ASSIST DEVICE; MYOCARDIAL PERFUSION IMAGING; PACEMAKER; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION EXPOSURE; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

CORONARY ARTERY DISEASE; CORONARY CIRCULATION; HUMANS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84989360906     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.116.176214     Document Type: Editorial

References (18)

1. Dilsizian V, Bacharach SL, Beanlands RS, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. In press.
2. Clinical quality measures basics. CMS.gov website. https://www.cms.gov/regulations-And-guidance/legislation/ehrincentiveprograms/clinicalqualitymeasures.html. Accessed May 24, 2016.
3. Flachskampf FA, Dilsizian V. Leaning heavily on PET myocardial perfusion for prognosis. JACC Cardiovasc Imaging. 2014;7:288-291.
4. Schindler TH, Dilsizian V. PET-determined hyperemic myocardial blood flow: further progress to clinical application. J Am Coll Cardiol. 2014;64:1476-1478.
5. Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging. 2010;3:623-640.
6. Herzog BA, Husmann L, Valenta I, et al. Long-Term prognostic value of 13Nammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150-156.
7. Ziadi MC, deKemp RA, Williams KA, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740-748.
8. Dilsizian V. Transition from SPECT to PET myocardial perfusion imaging: A desirable change in nuclear cardiology to approach perfection. J Nucl Cardiol. 2016;23:337-338.
9. Dilsizian V, Taillefer R. Journey in evolution of nuclear cardiology: Will there be another quantum leap with the F-18 labeled myocardial perfusion tracers? JACC Cardiovasc Imaging. 2012;5:1269-1284.
10. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 1983;67:766-778.
11. Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and meta-Analysis including the Ontario experience. J Nucl Med. 2012;53:241-248.
12. Dilsizian V. 2014 SNMMI highlights lecture: cardiovascular imaging. J Nucl Med. 2014;55(10):9N-15N.
13. Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616- 1625.
14. Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18Ffluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61: 2374-2382.
15. Dilsizian V, Achenbach S, Narula J. On adding versus selecting imaging modalities for incremental diagnosis: A case-study of 18F-fluorodeoxyglucose PET/CT in prosthetic valve endocarditis. JACC Cardiovasc Imaging. 2013;6:1020-1021.
16. Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep. 2014;16:459.
17. Kim J, Feller ED, Chen W, Dilsizian V. FDG PET-CT imaging for LVAD associated infections. JACC Cardiovasc Imaging. 2014;7:839-842.
18. Dilsizian V. 2015 SNMMI highlights lecture: cardiovascular nuclear and molecular imaging. J Nucl Med. 2015;56(9):13N-19N.